The current status of PARP inhibitors in ovarian cancer
Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis
Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons
Ewing sarcoma in patients over 40 years of age: a prospective analysis of 31 patients treated at a single institution
Comparative study of different histologic classifications in the degree of differentiation in endometrial adenocarcinoma
Definitive chemoradiation for non-small-cell lung cancer: could a consensus be reached?
Combined therapy with dabrafenib and trametinib in BRAF -mutated metastatic melanoma in a real-life setting: the INT Milan experience
Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method
Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas
Tumor-associated trypsin inhibitor in patients with endometrial cancer
Orbital exenteration: our experience
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer